​

Funding Round

Series B - Alnara Pharmaceuticals

Series B - Alnara Pharmaceuticals

Investment Firm

Overview

Alnara Pharmaceuticals develops and commercializes orally-delivered protein therapeutics for the treatment of metabolic diseases.

Announced Date

Jan 28, 2010

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

MPM Capital

MPM Capital

MPM Capital is a early_stage_venture and late_stage_venture and private_equity and seed firm.

Participant Investors

1

Investor Name
Participant InvestorMPM Capital

Round Details and Background

Alnara Pharmaceuticals raised $35000000 on 2010-01-28 in Series B

Alnara Pharmaceuticals develops and commercializes orally-delivered protein therapeutics for the treatment of metabolic diseases.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 28, 2010
Series B - Alnara Pharmaceuticals
1-35.0M
Oct 30, 2008
Series A - Alnara Pharmaceuticals
4-20.0M

Recent Activity

There is no recent news or activity for this profile.